Literature DB >> 165602

The augmentation of tumor-specific immunity with immune RNA.

P J Deckers, B S Wang, P A Stuart, J A Mannick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 165602

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Studies of interaction of immune RNA with normal spleen cells.

Authors:  R Slomski; A M Latos
Journal:  Mol Cell Biochem       Date:  1977-09-09       Impact factor: 3.396

2.  Anti-tumour cytotoxicity of poly(A)-containing messenger RNA isolated from tumour-specific immunogenic RNA.

Authors:  C J Greenup; D A Vallera; K J Pennline; B J Kolodziej; M C Dodd
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

3.  Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.

Authors:  K J Pennline; S B Evans; J F Nawrocki; J C Rees; C S Johnson; D A Vallera; M C Dodd
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.